Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 19.60
-0.11 (-0.56%)
Nov 11, 2026, 4:08 PM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 2.78 billion as of November 10, 2026. It is the 16,815th most valuable company in the world and the 743rd biggest in Hong Kong. Its market cap has decreased by 35.99% in one year.
Market Cap
2.78B
Enterprise Value
1.64B
Revenue
635.93M
Global Rank
Country Rank
#743 Hong Kong
PE Ratio
14.25
ChartMarket Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 2.78B, a decrease of -36.36%. That is a compound annual growth rate of -28.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 2.78B | -35.70% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirxes Holding Company | 3.66B |
| TransThera Sciences (Nanjing) | 3.27B |
| Qyuns Therapeutics | 3.24B |
| Beijing Luzhu Biotechnology | 3.06B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.93B |
| Viva Biotech Holdings | 2.74B |
| Laekna | 2.74B |